ALC:NYSE
Alcon AG
69,99 USD
arrow_downward
-0,01%(-0,010) 1D
26-окт., 16:00:06 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALC...
Mkt. cap
29,09 млд
Avg. vol.
1,77 млн
Volume
2,82 миң
52-wk high
87,64 USD
52-wk low
61,84 USD
Beta
0,88
Shares outstanding
483,40 млн
No. of employees
25 миң
Mkt. cap
29,09 млд
Avg. vol.
1,77 млн
Volume
2,82 миң
52-wk high
87,64 USD
52-wk low
61,84 USD
Beta
0,88
Shares outstanding
483,40 млн
No. of employees
25 миң
News stories
From web sources and news partners
Nasdaq
·
1 мүнөт мурун
Victory Capital Becomes the First ETF Issuer to Dual List on Nasdaq Texas
StreetInsider
·
25 мүнөт мурун
Enlivex Announces Receipt of Delisting Notice from Nasdaq; Intends to Appeal
Barchart.com
·
47 мүнөт мурун
PayPal (NASDAQ:PYPL) reports sales below analyst estimates in Q3 2026 earnings
CNBC
·
2 саат мурун
GM will switch to Nasdaq from the NYSE on Nov. 17
Profile
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
About Alcon AG
CEODavid J. Endicott
Employees25 миң
Founded1945
HeadquartersЖенева, Женева, Швейцария
SectorMedical device
Websitealcon.com